Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes

Cell Rep. 2022 Dec 13;41(11):111792. doi: 10.1016/j.celrep.2022.111792.

Abstract

Glucagon secretion from pancreatic alpha cells is crucial to prevent hypoglycemia. People with type 1 diabetes lose this glucoregulatory mechanism and are susceptible to dangerous hypoglycemia for reasons still unclear. Here we determine that alpha cells in living pancreas slices from donors with type 1 diabetes do not mount an adequate glucagon response and cannot activate the positive autocrine feedback mediated by AMPA/kainate glutamate receptors. This feedback is required to elicit full glucagon responses in the healthy state. Reactivating residual AMPA/kainate receptor function with positive allosteric modulators restores glucagon secretion in human slices from donors with type 1 diabetes as well as glucose counterregulation in non-obese diabetic mice. Our study thus identifies a defect in autocrine signaling that contributes to alpha cell failure. The use of positive allosteric modulators of AMPA/kainate receptors overcomes this deficiency and prevents hypoglycemia, an effect that could be used to improve the management of diabetes.

Keywords: CP: Metabolism; NOD mouse; glucagon secretion; glucose counterregulation; glutamate receptors; hypoglycemia; living pancreas slices; pancreatic alpha cell; type 1 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Glucose
  • Diabetes Mellitus, Experimental*
  • Diabetes Mellitus, Type 1*
  • Glucagon
  • Glucagon-Secreting Cells*
  • Humans
  • Hypoglycemia*
  • Insulin
  • Mice
  • Receptors, Glutamate
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid

Substances

  • Glucagon
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • Receptors, Glutamate
  • Insulin
  • Blood Glucose